<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ920210-0141</DOCNO><DOCID>920210-0141.</DOCID><HL>   Technology:   Immune Response   In Talks on Vaccine   For Treating HIV</HL><DATE>02/10/92</DATE><SO>WALL STREET JOURNAL (J), PAGE B11</SO><CO>   F.INM IMNR RP.C RPR RPU</CO><MS>BASIC MATERIALS (BSC)CONSUMER NON-CYCLICAL (NCY)TECHNOLOGY (TEC)</MS><IN>BIOTECHNOLOGY (BTC)COMMODITY CHEMICALS (CHC)CHEMICALS, PLASTICS (CHM)DRUG MANUFACTURERS (DRG)MEDICAL andamp; BIOTECHNOLOGY, GENETIC RESEARCH, PROSTHETICS (MTC)</IN><NS>JOINT VENTURES (JVN)</NS><RE>CALIFORNIA (CA)EUROPE (EU)FRANCE (FR)NORTH AMERICA (NME)PENNSYLVANIA (PA)PACIFIC RIM (PRM)UNITED STATES (US)WESTERN EUROPE (WEU)</RE><LP>   SAN DIEGO -- Immune Response Corp. said it and two largedrug concerns have begun discussions about forming a jointventure to manufacture Immune Response's vaccine for thetreatment ofHIV infection, which causes AIDS.   The other firms are Rhone-Poulenc Rorer Inc., aninternational pharmaceutical company, and the Pasteur MerieuxConnaught Group, a large vaccine manufacturer and asubsidiary of Institut Merieux and Rhone-Poulenc S.A.</LP><TEXT>   Immune Response is a biopharmaceutical concern engaged indeveloping products for treatment of HIV infection and suchother autoimmune diseases as rheumatoid arthritis.   Immunization Products Ltd., a joint venture between ImmuneResponse and Rhone-Poulenc Rorer, is conducting clinicaltrials of the HIV therapeutic vaccine on humans in the U.S.The trials are scheduled to be completed later this year. ThePrimary objective is to support a product license applicationfor 1993 and to secure Food and Drug Administration approvalfor commerical marketeting of the HIV vaccine, ImmuineResponse said.   The Immune Response vaccine is based on a scientificapproach first suggested by Dr. Jonas Salk, a founder ofImmune Response and developer of the Salk polio vaccine. Dr.Salk proposed using whole but inactivated AIDS viruses toinoculate people already infected. Where other researchersuse genetically engineered or synthetic virus proteins, Dr.Salk chose to use live viruses killed with gamma radiation.</TEXT></DOC>